These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21069304)

  • 21. Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2012; 67-68():169-74. PubMed ID: 22579602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
    Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
    J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved impurity fingerprinting of heparin by high resolution (1)H NMR spectroscopy.
    Bigler P; Brenneisen R
    J Pharm Biomed Anal; 2009 May; 49(4):1060-4. PubMed ID: 19211212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphate.
    Sassaki GL; Riter DS; Santana Filho AP; Guerrini M; Lima MA; Cosentino C; Souza LM; Cipriani TR; Rudd TR; Nader HB; Yates EA; Gorin PA; Torri G; Iacomini M
    Analyst; 2011 Jun; 136(11):2330-8. PubMed ID: 21494716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
    Alban S; Lühn S; Schiemann S
    Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
    Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.
    Beyer T; Diehl B; Randel G; Humpfer E; Schäfer H; Spraul M; Schollmayer C; Holzgrabe U
    J Pharm Biomed Anal; 2008 Sep; 48(1):13-9. PubMed ID: 18678460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
    Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Analyst; 2000 May; 125(5):933-8. PubMed ID: 10885058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra.
    Rudd TR; Gaudesi D; Lima MA; Skidmore MA; Mulloy B; Torri G; Nader HB; Guerrini M; Yates EA
    Analyst; 2011 Apr; 136(7):1390-8. PubMed ID: 21279244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
    Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
    Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
    Volpi N; Maccari F; Linhardt RJ
    Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
    Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of dermatan sulfate and chondroitin sulfate as related substances in heparin by capillary electrophoresis.
    Bendazzoli C; Liverani L; Spelta F; Prandi M; Fiori J; Gotti R
    J Pharm Biomed Anal; 2010 Dec; 53(5):1193-200. PubMed ID: 20674212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of heparin impurities with HPLC-NMR using weak anion exchange chromatography.
    Limtiaco JF; Jones CJ; Larive CK
    Anal Chem; 2009 Dec; 81(24):10116-23. PubMed ID: 19911825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [NMR analysis of a contaminant in heparin].
    Yamaguchi H; Shinagawa M; Shimba N; Miyano H; Suzuki E
    Yakugaku Zasshi; 2008 Oct; 128(10):1513-5. PubMed ID: 18827473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
    Wielgos T; Havel K; Ivanova N; Weinberger R
    J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of an FIA-CD strategy for screening sulfated polysaccharides using antimalarial drugs and related species as probes.
    Stanley FE; Warner AM; Stalcup AM
    Anal Bioanal Chem; 2011 Jan; 399(2):707-16. PubMed ID: 20941481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.